Korsuva
Payments companies reported to CMS as associated with Korsuva. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Korsuva, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Korsuva
These are the largest totals companies reported as associated with Korsuva. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Anjay Rastogi | Los Angeles, CA | Nephrology (Internal Medicine) | $30,364.98 |
| Jessica Coleman | Beaufort, SC | Nephrology (Internal Medicine) | $24,251.03 |
| Kevin Griffiths | Washington, DC | Internal Medicine | $23,326.45 |
| Precious Hodges | Lafayette, LA | Acute Care (Nurse Practitioner) | $20,966.81 |
| Charuhas Thakar | Cincinnati, OH | Nephrology (Internal Medicine) | $18,267.20 |
| Christopher Gisler | Pittsburgh, PA | Nephrology (Internal Medicine) | $17,125.65 |
| Rodolfo Batarse | Rancho Mirage, CA | Nephrology (Internal Medicine) | $14,223.97 |
| William Dahms | Newark, DE | Nephrology (Internal Medicine) | $13,124.84 |
| Crystal Gardner-Martin | Livonia, MI | Nephrology (Internal Medicine) | $8,751.92 |
| Ashley Wozniak | Livonia, MI | Acute Care (Nurse Practitioner) | $8,443.19 |
Prescribed Korsuva?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.